US: Mead Johnson hails "strong" 2013 but shares down on 2014 forecasts
Mead Johnson has posted an 8% sales increase for Q4 2013
US infant formula group Mead Johnson today (31 January) booked higher annual sales and profits but its shares fell after its forecast for 2014 earnings fell below Wall Street estimates.
The company booked a 7.4% rise in net earnings to US$649.5m for 2013. EBIT was $924.6m, compared to $870m in 2012.
Sales increased 8% to $4.2bn thanks to higher prices and volumes.
"We are pleased with our strong 2013 performance as we achieved sales growth at the top end of our guidance range and earnings that exceeded expectations," CEO Kasper Jakobsen said.
However, Mead Johnson's forecast for 2014 full-year non-GAAP earnings per share of $3.50 to $3.62 was below Wall Street estimates. Analysts surveyed by Thomson Reuters had forecast $3.67 a share.
Mead Johnson's stock was down 1% at $78.58 at 12:02 ET.
For the full results, click here.
This report analyzes the worldwide markets for Baby Foods and Infant Formula in US$ by the following Product Segments: Infant Formula (Baby Milks/Baby Formulas), Baby Meals, Baby Cereals, Baby Juices/...
About Baby Food and Infant Formulas Infant formula is either a partial or a total substitute for breast milk for infants under one year old. Baby food products, available in the market, are specially...
- just-food's pick: Innovation on show at ISM 2016
- Mondelez results and outlook - 7 things to learn
- What are the implications of Brexit for UK food?
- Richelieu Foods CEO eyes growth - interview
- Foodservice focus: McDonald's/Five Guys/Starbucks
- Chobani targets growth after rejecting offers
- Mars to cut artificial colours from global foods
- Private-equity firm HKW acquires Panos Brands
- WWF launches food security platform
- Arla eyes job cuts as part of 2020 growth push